These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2046094)

  • 21. A dermatologist's perspective on the final sunscreen monograph.
    Draelos ZD
    J Am Acad Dermatol; 2001 Jan; 44(1):109-10. PubMed ID: 11148485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choosing an expected sun protection factor value.
    Sica JR; Caswell M
    J Cosmet Sci; 2015; 66(2):87-93. PubMed ID: 26454973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simplifying sun safety: a guide to the new FDA sunscreen monograph.
    Bronfenbrener R
    Cutis; 2014 Apr; 93(4):E17-9. PubMed ID: 24818187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The FDA final rule on labeling and effectiveness testing of sunscreens: too little, too late?
    Diffey B
    J Am Acad Dermatol; 2012 Jan; 66(1):162-3. PubMed ID: 22177641
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro assessments of UVA protection by popular sunscreens available in the United States.
    Wang SQ; Stanfield JW; Osterwalder U
    J Am Acad Dermatol; 2008 Dec; 59(6):934-42. PubMed ID: 18835064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. UV protection and sunscreens: what to tell patients.
    Jou PC; Feldman RJ; Tomecki KJ
    Cleve Clin J Med; 2012 Jun; 79(6):427-36. PubMed ID: 22660875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FDA approves once-daily efavirenz formulation, revised labeling.
    AIDS Treat News; 2002 Mar; (378):7. PubMed ID: 11965921
    [No Abstract]   [Full Text] [Related]  

  • 28. Attack on Sunscreens Continues.
    Epstein H
    Skinmed; 2021; 19(4):301-302. PubMed ID: 34526206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revised FDA labeling guideline for theophylline oral dosage forms.
    Hendeles L; Jenkins J; Temple R
    Pharmacotherapy; 1995; 15(4):409-27. PubMed ID: 7479193
    [No Abstract]   [Full Text] [Related]  

  • 30. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of new regulations for pediatric labeling by the Food and Drug Administration.
    Buck ML
    Pediatr Nurs; 2000; 26(1):95-6. PubMed ID: 12026326
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA notifications. New labeling for N-9 products?
    AIDS Alert; 2003 Mar; 18(3):40. PubMed ID: 12635610
    [No Abstract]   [Full Text] [Related]  

  • 33. Pediatric Sunscreen and Sun Safety Guidelines.
    Julian E; Palestro AM; Thomas JA
    Clin Pediatr (Phila); 2015 Oct; 54(12):1133-40. PubMed ID: 26130395
    [No Abstract]   [Full Text] [Related]  

  • 34. Delegations of authority and organization; issuance of written notices--FDA. Final rule.
    Fed Regist; 1992 May; 57(85):18823-4. PubMed ID: 10118461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New FDA rule affects drug labeling.
    J Am Vet Med Assoc; 1998 Sep; 213(5):598. PubMed ID: 9731244
    [No Abstract]   [Full Text] [Related]  

  • 36. Safety-related drug labeling changes approved by FDA.
    White GG
    J Toxicol Clin Toxicol; 1998; 36(3):265-7. PubMed ID: 9678979
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA proposes more stringent pediatric-use labeling of prescription drug products.
    Clin Pharm; 1993 Jan; 12(1):6. PubMed ID: 8428434
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA considers OTC drug labeling reform.
    Am Pharm; 1995 Nov; NS35(11):5-6. PubMed ID: 8533722
    [No Abstract]   [Full Text] [Related]  

  • 39. Food and Drug Administration's proposed sunscreen final administrative order: How does it affect sunscreens in the United States?
    Lim HW; Mohammad TF; Wang SQ
    J Am Acad Dermatol; 2022 Feb; 86(2):e83-e84. PubMed ID: 34606770
    [No Abstract]   [Full Text] [Related]  

  • 40. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(238):69009-20. PubMed ID: 14672084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.